|
|
|
| Application effect of Flurbiprolol Ester combined with Propofol in painless transvaginal oocyte retrieval |
| QING Zhao-hui1，2，3 PENG Shao-qin1，2，3 XU Qing-wei1，2，3 XU Xiao-tong1，2，3 |
1. Department of Anesthesiology, Guangdong Institute of Family Planning Science and Technology, Guangzhou 510600, China;
2. Department of Anesthesiology, Guangdong Family Planning Hospital, Guangzhou 510600, China;
3. Key Laboratory of Male Reproduction and Genetics, National Health Commission, Guangdoug Province, Guangzhou 510600, China |
|
|
|
|
Abstract Objective To observe the aapplication effect of Flurbiprolol Ester combined with Propofol in painless transvaginal oocyte retrieval. Methods A total of 60 patients in Family Planning Hospital of Guangdong Province from October to December 2019 were selected as the study subjects, and they were divided into Flurbiprolol Ester combined with Propofol group (group F, n=30) and Propofol group (group B, n=30) according to the random number table method.The total amount of Propofol, the total time duration of anesthesia, the total time of operation, the total amount of Propofol supplementation, the number of intraoperative body movements, postoperative abdominal pain and postoperative adverse reactions were compared between the two groups. Results The total amount of Propofol, the total amount of Propofol supplementation in the group F were lower than those in the group B, with statistical differences (P＜0.05). The total time duration of anesthesia in the group F was shorter than that in the group B, with statistical difference (P＜0.05). The number of intraoperative body movements (10.0%), postoperative abdominal pain (6.7%) and incidence of adverse events (23.3%) in the group F were lower than those in the group B (23.3%, 16.7%, 46.7%), with statistical differences (P＜0.05). Conclusion Applicationc effect of Flurbiprolol Ester combined with Propofol in painless transvaginal oocyte retrieval is a relatively safe and effective method to reduce the total dosage of Propofol, the total amount of Propofol added, the body movement and respiratory inhibition, the incidence of postoperative abdominal pain，and shortening the patient waking hours
|
|
Received: 09 May 2020
|
|
|
|
| [1] |
苑辉，张岭山，王娜.针刺联合电针治疗在体外受精-胚胎移植取卵术中镇痛效果评价[J].中医外治杂志，2017，26（3）：38-39.
|
| [2] |
李翠茹，杨英，赵航英.针对性信息宣教联合情感支持对不孕症患者心理健康及家庭功能影响[J].山西医药杂志，2018，47（15）：1845-1847.
|
| [3] |
吴桂杰，郑慧玲，蔡敏，等.精准宣教路径在首次试管婴儿助孕患者中的应用及评价[J].中国妇幼保健，2019，34（3）：620-623.
|
| [4] |
王治鸿，刘翔华，杨盼，等.不同促排卵方案下受精情况及妊娠结局的观察[J].山西医科大学学报，2018，49（11）：1391-1394.
|
| [5] |
Wang HY，Ting CK，Liou JY，et al.A previously published propofol remifentanil response surface model dose not predict patient response well in video-assisted thoracic surgery[J].Medicine，2017，96（19）：e6895.
|
| [6] |
古安城，曹婉雯，张建萍，等.CYP2B6*6 基因多态性对中国健康受试者单次注射丙泊酚的药代动力学和药效学影响[J].中国临床药理学杂志，2018，34（9）：1052-1055.
|
| [7] |
张恒，饶坤林，黄隽敏.氟比洛酚酯复合丙泊酚麻醉用于无痛人流术超前镇痛临床效果的Meta 分析[J].中国医药导报，2017，14（30）：115-120.
|
| [8] |
刘龙娟，孔重红.不同剂量瑞芬太尼对丙泊酚靶控输注诱导期效应室浓度和麻醉深度的影响[J].医药导报，2019，38（6）：742-746.
|
| [9] |
王怡鸾，南洋，王倩，等.靶控输注时丙泊酚镇静效力的影响因素[J].温州医科大学学报，2019，49（6）：427-431.
|
| [10] |
周俊辉，孟睿，刘晓乐，等.纳布啡复合丙泊酚用于无痛结肠镜检查术的临床效果[J].医学研究杂志，2017，46（2）：112-116.
|
| [11] |
杨晴，马传根，张义轩，等.右美托咪定在纳布啡联合氟比洛芬酯术后PCIA 中的镇痛效果[J].临床麻醉学杂志，2018，34（5）：497-498.
|
| [12] |
肖海.右美托咪定与丙泊酚用于门诊无痛人流术中麻醉效果的分析[J].医药前沿，2017，7（29）：33-35.
|
| [13] |
熊秋菊，刘小男，何开华，等.连续腰丛神经阻滞联合多模式镇痛在髋关节翻修术术后镇痛中的效果评价[J].重庆医科大学学报，2017，15（5）：560-564.
|
| [14] |
王迎虎.氟比洛芬酯的药理及临床应用进展[J].天津药学，2018，30（2）：58-71.
|
| [15] |
刘浩，郭代红，宋艳东，等.氟比洛芬（酯）引起的肝损伤病例报告及文献评价[J].中国药物警戒，2018，15（5）：291-295.
|
|
|
|
